Alessandro Bertolini

1.6k citations
22 papers · 760 · 1 hit paper · h-index 11

Impact in

  • Oncology top 5%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Brain Metastases and Treatment
    • Lung Cancer Diagnosis and Treatment

Papers in

Alessandro Bertolini

22 papers receiving 745 citations

Alessandro Bertolini's Hit Papers

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer 2018 · 511 citations
5110+2+5Years since publication100200300400500

Peers

Alessandro Bertolini
Comparison fields: 5 of 56
  • Oncology 515
  • Pulmonary and Respiratory Medicine 532
  • Genetics 60
  • Cancer Research 65
  • Toxicology 8
Replace Francesca Mazzoni with:
Francesca Mazzoni Italy
T.S. Maughan United Kingdom
Ryo Toyozawa Japan
Raphael Brandão Moreira United States
J. Crawford United States
L Portalone Italy
Ramón Palmero Spain
Johann Raats South Africa
Kiichiro Ninomiya Japan
María Carmen Riesco Martínez Spain
Alessandro Bertolini relative to Francesca Mazzoni Italy Francesca Mazzoni's profile →
Citations per field
00.5×1.5×
Francesca Mazzoni · 1×
Citations per year

Countries citing papers authored by Alessandro Bertolini

Since Specialization
Citations

This map shows the geographic impact of Alessandro Bertolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Bertolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Bertolini more than expected).

Fields of papers citing papers by Alessandro Bertolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Bertolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Bertolini. The network helps show where Alessandro Bertolini may publish in the future.

Co-authors

The 25 scholars most cited alongside Alessandro Bertolini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alessandro Bertolini Line = papers co-authored together Alessandro Bertolini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2018511
2 201076
3 200135
4 200327
5 201515
6 201113
7 201412
8 201311
9 201311
10 201511
11 201510
12 20174
13 20074
14 20083
15 20213
16 20233
17 20083
18 20193
19 19872
20 20161

About Alessandro Bertolini

Alessandro Bertolini is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Cancer Research and Molecular Biology, having authored 22 papers that have together received 760 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Genetic factors in colorectal cancer (2 papers), Iron Metabolism and Disorders (2 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Oncology (515 citations), Pulmonary and Respiratory Medicine (532 citations), Genetics (60 citations), Cancer Research (65 citations) and Toxicology (8 citations). Alessandro Bertolini has collaborated with scholars based in Italy, Switzerland and Japan. Frequent co-authors include Suresh S. Ramalingam, Thanyanan Reungwetwattana, Isamu Okamoto, Rachel Hodge, Ki Hyeong Lee, Byoung Chul Cho, Sabine Bohnet, Astrid McKeown, Natasha B. Leighl and Yuri Rukazenkov. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancers, Scientific Reports and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact